Evidence map›Paper›PMID 3302929›Full record

ReviewPharmaceutisch weekblad. Scientific edition1987

Liposomes in treatment of infectious diseases.

F Emmen, G Storm

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pharmaceutisch weekblad. Scientific edition, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1993
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

F Emmen
G Storm
Utrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In reviewing the literature about the potential of liposomes in the therapy of infections caused by protozoa, bacteria, fungi and viruses, it can be concluded that liposomal encapsulation may improve the therapeutic index of anti-infectious drugs. The improved therapeutic index may be a result of a reduction in drug toxicity and/or an enhanced drug delivery at the intracellular site of infection. Furthermore, attention is paid to the therapeutic utility of liposome-encapsulated immunomodulators in treatment of infections.

Indexed as

Adjuvants, ImmunologicAnimalsAnti-Bacterial AgentsAntifungal AgentsAntiprotozoal AgentsInfectionsLiposomesAdjuvants, ImmunologicAnti-Bacterial AgentsAntifungal AgentsAntiprotozoal AgentsLiposomes

Identifiers

PMID3302929
OpenAlexW2094675502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.